Linda A. Sherman

Linda A. Sherman

Auto-generated profile, based on publicly available information

Linda A. Sherman

Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, CA 92037

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1980 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
FLF T Liu
F T Liu
JBJ W Bohn
J W Bohn
EFE L Ferry
E L Ferry
HYH Yamamoto
H Yamamoto
CMC A Molinaro
C A Molinaro
DKD H Katz
D H Katz
A murine hybridoma secreting monoclonal IgE antibodies of anti-2,4-dinitrophenyl (DNP) specificity was generated by fusion of SP2/0 tumor cells and spleen cells from DNP-Ascaris-hyperimmunized mice. Hybridomas secreting anti-DNP antibodies of other heavy chain classes, i.e., μ, γ1 and γ2b, were also obtained from the same fusion experiment. Large quantities of IgE antibodies were obtained from ascites of mice in which the IgE-secreting hybridoma was propagated in vivo. The IgE antibodies were isolated by precipitation with ammonium sulfate followed by afinity chromatography on DNP-bovine serum albumin (BSA)-Sepharose-4B and further purified by ion-exchange chromatography on DEAE-cellulose and gel filtration on Sephadex G-200. The isolated IgE has an approximate m.w. of 184,000, a total carbohydrate content of 13.3%, and its amino acid composition has been determined. The antibody has an association constant with DNP-lysine of 1.4 × 108 M-1 at 25°C and 7.1 × 107 M-1 at 37°C. Rabbit and goat antibodies against the hybridoma IgE were prepared and the antisera were made specific for IgE by adsorption on normal mouse serum protein-Sepharose-4B. Solid phase radioimmunoassays for measuring murine antigen-specific and total IgE were developed and were shown to have high specificity and sensitivity. Finally, the isolated hybridoma IgE can mediate antigen (DNP-BSA)-induced release of mediator (serotonin) from rat basophilic leukemia cells.

31 October 2010 in Cancer Research
Verified
Journal Article
Closed access
PDF file
RBRinke Bos
Rinke Bos
LSLinda A. Sherman
Linda A. Sherman
CD4 help for CD8+ T lymphocytes prevents tolerance and promotes the survival of effector and memory CD8+ T cells. Here, we describe additional helper functions that require CD4+ T cells within the tumor environment. CD8+ T-cell recruitment, proliferation, and effector function within the tumor were greatly enhanced by tumor-specific CD4+ T cells. Recruitment of CD8+ T cells was accelerated by IFN-γ–dependent production of chemokines. Production of interleukin-2 by tumor resident CD4+ T cells enhanced CD8+ T-cell proliferation and upregulated expression of granzyme B. These results highlight a novel role for tumor-specific CD4+ T cells in promoting CD8+ T-cell recruitment and cytolytic function, two previously unappreciated aspects of tumor-specific CD4 help. Cancer Res; 70(21); 8368–77. ©2010 AACR.

1 April 1991 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AVA Vitiello
A Vitiello
DMD Marchesini
D Marchesini
JFJ Furze
J Furze
LSL A Sherman
L A Sherman
RCR W Chesnut
R W Chesnut
Transgenic murine lines have been constructed that express a chimeric class I molecule composed of the alpha 1 and alpha 2 domains of HLA-A2.1 and the alpha 3, transmembrane, and cytoplasmic domains of H-2Kb. Upon immunization with influenza virus, transgenic mice developed a strong A2.1Kb-restricted cytotoxic T lymphocyte (CTL) response specific for the same matrix protein epitope that serves as the dominant A2.1-restricted determinant in the equivalent human response. Fine specificity analysis of CTL clones using truncated peptides revealed strong similarity between the response repertoire of transgenic mice and that previously reported using influenza-specific A2.1-restricted CTL clones from humans. This suggests that even when considering T cell responses by different species, the alpha 1 and alpha 2 domains of the restriction element play a dominant role in determining the CTL specific repertoire. Thus, substituting the alpha 3 domain of A2.1 with a murine counterpart has permitted development of a transgenic strain that should serve as an excellent model system in studies of HLA-restricted responses.

1 August 1996 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
DMD J Morgan
D J Morgan
RLR Liblau
R Liblau
BSB Scott
B Scott
SFS Fleck
S Fleck
HMH O McDevitt
H O McDevitt
LSL A Sherman
L A Sherman
Transgenic mice that express the influenza virus hemagglutinin (HA) on pancreatic islet β cells (ins-HA) demonstrate tolerance of HA even after immunization with influenza virus. Surprisingly, when Ins-HA mice were mated with a transgenic mouse expressing a TCR specific for an epitope of HA that is restricted by MHC class I H-2Kd (Clone-4 TCR), the resulting double transgenic (Ins-HA x Clone-4 TCR)F1 neonates developed spontaneous autoimmune diabetes immediately after birth and died within 10 days. This represents a unique situation in which all safeguards within the immune system that normally maintain tolerance of self-antigens in the neonate are insufficient.

19 December 1995 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MTM Theobald
M Theobald
JBJ Biggs
J Biggs
DDDirk P. Dittmer
Dirk P. Dittmer
ALA J Levine
A J Levine
LSL A Sherman
L A Sherman
A major barrier to the design of immunotherapeutics and vaccines for cancer is the idiosyncratic nature of many tumor antigens and the possibility that T cells may be tolerant of broadly distributed antigens. We have devised an experimental strategy that exploits species differences in protein sequences to circumvent tolerance of high-affinity T cells. HLA transgenic mice were used to obtain cytotoxic T lymphocytes specific for peptides from the human p53 tumor-suppressor molecule presented in association with HLA-A2.1. Although such p53-specific cytotoxic T cells did not recognize nontransformed human cells, they were able to lyse a wide variety of human tumor cells lines, thus confirming the existence of broadly distributed determinants that may serve as targets for immunotherapy.

15 September 1998 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TKTal Kafri
Tal Kafri
DMDavid Morgan
David Morgan
TKTroy Krahl
Troy Krahl
NSNora Sarvetnick
Nora Sarvetnick
LSLinda Sherman
Linda Sherman
IVInder Verma
Inder Verma
Replication-defective adenoviral (RDAd) vectors can be generated at high titers and infect both dividing and nondividing cells. Long term expression in the transduced tissue, however, has been a problem because of the cellular immune responses against the infected cells. We demonstrate that mice injected with RDAd vectors containing mouse leptin gene reduce food intake and lose weight for only 7 to 10 days. Splenocytes obtained from infected mice are able to lyse target cells infected with RDAd vectors. Surprisingly, target cells infected with psoralen-treated, UV-crosslinked, biologically inactive RDAd also were lysed efficiently by the effector cells. Furthermore, splenocytes obtained from mice injected with inactive RDAd vectors efficiently lysed target cells infected with RDAd vectors. Whether RDAd vectors were injected i.m. or i.v. or through an i.p. route, the extent of lysis was similar. We propose that cells infected with RDAd vectors present antigens for recognition by class 1 major histocompatibility complex-restricted cytotoxic T lymphocytes by a mechanism that does not require viral replication orde novoprotein synthesis. These results should prompt reevaluation of the use of RDAd vectors for gene therapy when long-term expression is required.